Best Tech Stocks To Buy And Watch Now: TSMC Headlines Five Top Stocks For June
Taiwan Semi is one of the best techs stocks to buy and watch now amid pronounced selling in the once high-flying software sector.
Taiwan Semi is one of the best techs stocks to buy and watch now amid pronounced selling in the once high-flying software sector.
One real estate expert says, “this is just the beginning.”
Consider investing in this monthly dividend stock at current levels to lock in high-yielding monthly distributions to create a good passive-income stream. The post This 8.39% Dividend Stock Can Pay $100 Cash Every Month appeared first on The Motley Fool Canada.
Three TSX stocks that continue to overcome massive headwinds and beat the market are no-brainer buys right now. The post 3 No-Brainer TSX Stocks I’d Buy Right Now Without Hesitation appeared first on The Motley Fool Canada.
The Bank of Nova Scotia ( TSE:BNS ) has announced that it will pay a dividend of CA$1.06 per share on the 29th of July...
Money expert Rubina Ahmed-Haq breaks down the federal government's changes to the capital gains tax. Learn how the new measures might affect you and your family and how the levy applies to inherited property.
With the combination of reliability and impressive long-term growth potential, this 5.7% dividend stock is one of the best on the TSX. The post Why I Keep Buying Shares of This 5.7%-Yielding Dividend Stock appeared first on The Motley Fool Canada.
A cash-gushing high-yield dividend stock continues to outperform and beat the TSX. The post Beat the TSX With This Cash-Gushing Dividend Stock appeared first on The Motley Fool Canada.
As far as top dividend stocks are concerned, Fortis (TSX:FTS) remains a top option long-term investors should consider right now. The post 3 Reasons to Buy Fortis Stock Like There’s No Tomorrow appeared first on The Motley Fool Canada.
While Nvidia stands as the undisputed winner of the AI chip wars, it soon could have a rival.
Don’t miss your chance to load up on this high-yielding, renewable energy growth stock. The post 1 Ridiculously Undervalued Growth Stock Down 40% to Buy Hand Over Fist appeared first on The Motley Fool Canada.
High costs aren’t helping.
Looking for stocks set to beat the market in 2024 and well beyond? Here are two tech stocks set to soundly beat the market from here. The post Prediction: My 2 Top TSX Stocks to Beat the Market in 2024 and Beyond appeared first on The Motley Fool Canada.
These under $30 Canadian growth stocks are well-positioned to capitalize on mega trends such as e-commerce, the electrification of vehicles, and digital transformation. The post 3 Canadian Growth Stocks I’d Buy Under $30 appeared first on The Motley Fool Canada.
These TSX stocks have the potential to offer worry-free dividends over the next decade while offering high yields. The post 3 Safe Dividend Stocks to Own for the Next 10 Years appeared first on The Motley Fool Canada.
BofA analyst Andrew Didora noted “modestly softer pricing” based on early June cruise prices. The cruise lines’ shares were the worst and second-worst performers in the S&P 500 Friday.
On Thursday evening, the index added Arm Holdings, the U.K. chip maker, and dropped Sirius XM Holdings in a move that Barron’s had predicted could happen.
Shopify stock fell 25% after reporting disappointing guidance. Should investors buy the dip and hold the stock for the long term? The post 3 Reasons to Buy Shopify Stock Like There’s No Tomorrow appeared first on The Motley Fool Canada.
The broker initiated coverage of the stock with an outperform rating and a $2,890 price target.
The stock has far outperformed the S&P 500. All of the car maker’s U.S. rivals are in the red this year.
A loss-making firm that applies artificial intelligence (AI) to drug research has become a new darling for both old-money and new-money investors in Hong Kong, drawn by the impressive credentials of its three founders, who trained at the Massachusetts Institute of Technology (MIT), as well as the endorsement of Tencent Holdings' billionaire founder Pony Ma Huateng. Nine-year-old QuantumPharm, which began trading on Thursday, raised nearly HK$1 billion (US$128 million) in an initial public offeri